Medpace Holdings, Inc.

MEDP

$585.76

Name : Medpace Holdings, Inc.

Sector : Healthcare

Industry: Diagnostics & Research

Mark. Cap: $16,499,819,520.00

EPSttm : 14.29

Medpace Holdings, Inc.

$585.76

0.73%

$4.33

Float Short %

5.81

Margin Of Safety %

-15

Put/Call OI Ratio

1.7

EPS Next Q Diff

-0.48

EPS Last/This Y

2.06

EPS This/Next Y

1.37

Price

586.01

Target Price

557.27

Analyst Recom

3.46

Performance Q

26.75

Relative Volume

0.49

Beta

1.43

Ticker: MEDP

21 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-10-20	MEDP	544.41	1.83	1.67	2341
2025-10-21	MEDP	546.14	1.82	1.78	2336
2025-10-22	MEDP	547.24	1.88	0.80	2610
2025-10-23	MEDP	596.97	1.49	1.40	3834
2025-10-24	MEDP	605.52	1.65	1.91	4507
2025-10-27	MEDP	596.62	1.66	1.18	4636
2025-10-28	MEDP	579.97	1.68	0.46	4714
2025-10-29	MEDP	584.33	1.74	1.55	4783
2025-10-30	MEDP	579.8	1.74	2.56	4794
2025-10-31	MEDP	584.88	1.74	0.26	4798
2025-11-03	MEDP	593.82	1.74	0.87	4803
2025-11-04	MEDP	594.55	1.73	2.08	4801
2025-11-05	MEDP	598.83	1.74	0.10	4808
2025-11-06	MEDP	591.76	1.70	2.00	4863
2025-11-07	MEDP	588.75	1.71	0.69	4884
2025-11-10	MEDP	600.51	1.71	1.26	4892
2025-11-11	MEDP	603	1.71	0.38	4924
2025-11-12	MEDP	598.47	1.71	2.00	4948
2025-11-13	MEDP	591.1	1.71	0.55	4943
2025-11-14	MEDP	590.09	1.70	0.77	4958
2025-11-17	MEDP	586.08	1.70	7.64	4968
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

21 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-10-20	MEDP	544.41	18.5	73.5	14.36
2025-10-21	MEDP	546.23	18.5	58.8	14.36
2025-10-22	MEDP	546.74	18.5	58.1	14.36
2025-10-23	MEDP	596.77	18.5	115.1	14.36
2025-10-24	MEDP	605.29	12.0	64.9	14.74
2025-10-27	MEDP	596.28	12.0	19.6	14.74
2025-10-28	MEDP	580.53	14.2	13.1	15.21
2025-10-29	MEDP	584.68	14.2	69.6	15.21
2025-10-30	MEDP	580.37	14.2	61.6	15.21
2025-10-31	MEDP	584.91	14.2	70.0	15.21
2025-11-03	MEDP	594.18	14.2	74.9	15.21
2025-11-04	MEDP	594.60	14.2	65.8	15.21
2025-11-05	MEDP	598.63	14.2	69.5	15.21
2025-11-06	MEDP	592.20	14.2	73.0	15.21
2025-11-07	MEDP	589.15	14.2	62.5	15.21
2025-11-10	MEDP	600.44	14.2	76.5	15.21
2025-11-11	MEDP	602.77	14.2	67.7	15.16
2025-11-12	MEDP	598.21	14.2	61.1	15.16
2025-11-13	MEDP	591.67	14.2	59.7	15.16
2025-11-14	MEDP	590.35	14.2	64.7	15.16
2025-11-17	MEDP	586.01	14.3	61.5	15.12
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-10-20	MEDP	-2.97	2.84	9.14
2025-10-21	MEDP	-2.97	2.84	9.14
2025-10-22	MEDP	-2.97	2.84	9.14
2025-10-23	MEDP	-2.97	2.84	9.14
2025-10-24	MEDP	-2.97	2.84	9.14
2025-10-27	MEDP	-2.96	3.26	7.38
2025-10-28	MEDP	-2.96	3.26	7.38
2025-10-29	MEDP	-2.93	3.26	7.36
2025-10-30	MEDP	-3.63	3.26	7.36
2025-10-31	MEDP	-3.63	3.26	7.36
2025-11-03	MEDP	-3.73	2.93	7.36
2025-11-04	MEDP	-3.73	2.93	7.36
2025-11-05	MEDP	-3.73	2.93	7.36
2025-11-06	MEDP	-3.73	2.93	7.36
2025-11-07	MEDP	-4.10	2.93	7.36
2025-11-10	MEDP	-4.10	-0.64	7.36
2025-11-11	MEDP	-4.10	-0.64	7.36
2025-11-12	MEDP	-4.41	-0.64	5.70
2025-11-13	MEDP	-4.41	-0.64	5.70
2025-11-14	MEDP	-4.58	-0.64	5.81
2025-11-17	MEDP	-4.27	-3.01	5.81
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

3.86

Avg. EPS Est. Current Quarter

4.21

Avg. EPS Est. Next Quarter

3.38

Insider Transactions

-4.27

Institutional Transactions

-3.01

Beta

1.43

Average Sales Estimate Current Quarter

689

Average Sales Estimate Next Quarter

679

Fair Value

499.64

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

6.2

Max Drawdown 5-Year %

-42.9

Target Price

557.27

P/E

40.97

Forward P/E

35.24

PEG

2.95

P/S

P/B

56.05

P/Free Cash Flow

24.38

EPS

14.3

Average EPS Est. Cur. Y

15.12

EPS Next Y. (Est.)

16.49

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

18.36

Relative Volume

0.49

Return on Equity vs Sector %

120.5

Return on Equity vs Industry %

136.5

EPS 1 7Days Diff

-0.1

EPS 1 30Days Diff

0.76

EBIT Estimation

61.5

Medpace Holdings, Inc.

Sector: Healthcare

Industry: Diagnostics & Research

Employees: 6200

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.

stock quote shares MEDP – Medpace Holdings, Inc. Stock Price stock today

news today MEDP – Medpace Holdings, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch MEDP – Medpace Holdings, Inc. yahoo finance google finance

stock history MEDP – Medpace Holdings, Inc. invest stock market

stock prices MEDP premarket after hours

ticker MEDP fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: MEDP

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Last Quarter Act. EPS

Average EPS Est. Cur. Y